Tarsus Pharmaceuticals, Inc.
TARS • NASDAQ
Tarsus Pharmaceuticals, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Bobak R. Azamian, with a market cap of $3.1B.
Market Cap$3.1B
Employees244.0
CEOBobak R. Azamian
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsApr 30, 2026 · In 2 weeksQ1 2026
Financials
Tarsus Pharmaceuticals, Inc. FAQ
Common questions about Tarsus Pharmaceuticals, Inc.
Tarsus Pharmaceuticals, Inc. is scheduled to report earnings for Q1 2026 on April 30, 2026. Analysts estimate revenue of $153.6M.
Tarsus Pharmaceuticals, Inc. has approximately 244 employees.